Complementarity-determining region 3 size spectratypes of T cell receptor β chains in CD8 + T cells following antiviral treatment of chronic hepatitis B

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 2, 2011, Pages 888-894

  Ma, Shi Wu ^a,b   Li, Yong Yin ^a   Zhang, Guang Wen ^a,c   Huang, Xuan ^a   Sun, Jian ^a   Li, Chris ^d   Abbott, William G H ^a,e   Hou, Jin Lin ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b KUNMING GENERAL HOSPITAL   (China)

^c XINXIANG MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 21; LAMIVUDINE; MESSENGER RNA; T LYMPHOCYTE RECEPTOR BETA CHAIN; TELBIVUDINE; VIRUS DNA;

ADULT; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; CD8+ T LYMPHOCYTE; CELL CLONING; CELL EXPANSION; CELLULAR IMMUNITY; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; FEMALE; GENE DOSAGE; GENETIC ANALYSIS; GENETIC VARIABILITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; ANTIVIRAL AGENTS; CD8-POSITIVE T-LYMPHOCYTES; COMPLEMENTARITY DETERMINING REGIONS; DOUBLE-BLIND METHOD; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; LYMPHOCYTE ACTIVATION; MALE; NUCLEOSIDES; POLYMERASE CHAIN REACTION; PYRIMIDINONES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78751698623     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01232-10     Document Type: Article

References (23)

1. Abbott, W. G., et al. 2010. Associations between HLA class I alleles and escape mutations in the hepatitis B virus core gene in New Zealand-resident Tongans. J. Virol. 84:621-629.
2. Bertoletti, A., et al. 1993. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J. Virol. 67:2376-2380. (Pubitemid 23088417)
3. Boni, C., et al. 2007. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J. Virol. 81:4215-4225. (Pubitemid 46586915)
4. Boni, C., et al. 2003. Transient restoration of antiviral T cell responses induced by lamivudine therapy in chronic hepatitis B. J. Hepatol. 39:595-605.
5. Boni, C., et al. 2001. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 33:963-971.
6. Hou, J., et al. 2008. Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: results at 1 year of a randomized, double-blind trial. Hepatology 47:447-454.
7. Inada, H., et al. 2000. T cell repertoire in the liver of patients with primary biliary cirrhosis. Hum. Immunol. 61:675-683.
8. Jacobsen, M., S. Cepok, W. H. Oertel, N. Sommer, and B. Hemmer. 2001. New approaches to dissect degeneracy and specificity in T cell antigen recognition. J. Mol. Med. 79:358-367.
9. Komatsu, Y., Y. Nawa, A. R. Bellamy, and J. Marbrook. 1978. Clones of cytotoxic lymphocytes can recognize uninfected cells in a primary response against influenza virus. Nature 274:802-804.
10. Lok, A. S. 2002. Chronic hepatitis B. N. Engl. J. Med. 346:1682-1683.
11. Lok, A. S., and B. J. McMahon. 2007. Chronic hepatitis B. Hepatology 45:507-539.
12. Long, S. A., et al. 2006. Standardized analysis for the quantification of Vβ CDR3 T-cell receptor diversity. J. Immunol. Methods 317:100-113.
13. + cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. 191:1269-1280.
14. + T-lymphocyte responses. J. Virol. 80:12032-12040.
15. Pantaleo, G., and A. Harari. 2006. Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat. Rev. Immunol. 6:417-423.
16. Parrish-Novak, J., et al. 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408:57-63.
17. Rehermann, B., et al. 1995. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181:1047-1058.
18. Schulbin, H., et al. 2008. Cytokine expression in the colonic mucosa of human immunodeficiency virus-infected individuals before and during 9 months of antiretroviral therapy. Antimicrob. Agents Chemother. 52:3377-3384.
19. Spolski, R., and W. J. Leonard. 2008. The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr. Opin. Immunol. 20:295-301.
20. Tan, A. T., et al. 2010. A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. J. Hepatol. 52:330-339.
21. Yang, L., et al. The presence of valine at position 27 of the hepatitis B virus core gene is associated with severe liver inflammation in Chinese patients. J. Med. Virol., in press.
22. Yao, X. S., et al. 2006. Analysis of the CDR3 length of TCR αβ T cells in the peripheral blood of patients with chronic hepatitis B. Hepatol. Res. 35:10-18.
23. Yoshizawa, K., et al. 1999. T cell repertoire in the liver of patients with autoimmune hepatitis. Hum. Immunol. 60:806-815.